Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Carlijn R. Lamers, Nicole M. de Roos, Coen C. W. G. Bongers, Dominique S. M. ten Haaf, Yvonne A. W. Hartman, Ben J. M. Witteman & Maria T. E. Hopman. (2021) Repeated prolonged moderate-intensity walking exercise does not appear to have harmful effects on inflammatory markers in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 56:1, pages 30-37.
Read now
Read now
Jun Kato, Takeichi Yoshida & Sakiko Hiraoka. (2019) Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 15:6, pages 667-677.
Read now
Read now
Christopher Ma, Robert Battat, Claire E. Parker, Reena Khanna, Vipul Jairath & Brian Gordon Feagan. (2019) Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease?. Expert Review of Gastroenterology & Hepatology 13:4, pages 319-330.
Read now
Read now
Lydia C. T. Buer, Bjørn A. Moum, Milada Cvancarova, David J. Warren, Nils Bolstad, Asle W. Medhus & Marte L. Høivik. (2019) Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort. Scandinavian Journal of Gastroenterology 54:1, pages 41-48.
Read now
Read now
Hu Zhang, Zhen Zeng, Arjudeb Mukherjee & Bo Shen. (2018) Molecular diagnosis and classification of inflammatory bowel disease. Expert Review of Molecular Diagnostics 18:10, pages 867-886.
Read now
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
Petr Ricanek, Lisa K Lunde, Stephan A Frye, Mari Støen, Ståle Nygård, Jens P Morth, Andreas Rydning, Morten H Vatn, Mahmood Amiry-Moghaddam & Tone Tønjum. (2015) Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease. Clinical and Experimental Gastroenterology 8, pages 49-67.
Read now
Read now
Fernando Magro, Paula Sousa & Paula Ministro. (2014) C-reactive protein in Crohn’s disease: how informative is it?. Expert Review of Gastroenterology & Hepatology 8:4, pages 393-408.
Read now
Read now
Klaus Theede, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen & Inge Nordgaard-Lassen. (2014) The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment. Scandinavian Journal of Gastroenterology 49:4, pages 418-423.
Read now
Read now
Darina Kohoutova, Miroslav Pecka, Michal Cihak, Jiri Cyrany, Jaroslav Maly & Jan Bures. (2014) Prevalence of hypercoagulable disorders in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 49:3, pages 287-294.
Read now
Read now
Dennis B. Holmgaard, Lone H. Mygind, Ingrid Titlestad, Hanne Madsen, Svend Stenvang Pedersen, Ole H. Mortensen & Court Pedersen. (2013) Calprotectin — A Marker of Mortality in COPD? Results from a Prospective Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:5, pages 581-587.
Read now
Read now
Petr Ricanek, Sheba M Lothe, Stephan A Frye, Andreas Rydning, Morten H Vatn & Tone Tønjum. (2012) Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn’s disease. Clinical and Experimental Gastroenterology 5, pages 173-186.
Read now
Read now
Roberta Caccaro, Renata D’Incà, Surajit Pathak & Giacomo Carlo Sturniolo. (2012) Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?. Expert Review of Clinical Immunology 8:6, pages 579-585.
Read now
Read now
. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:9, pages 1027-1028.
Read now
Read now
Articles from other publishers (72)
Keeley M. Fairbrass, Elspeth A. Guthrie, Christopher J. Black, Christian P. Selinger, David J. Gracie & Alexander C. Ford. (2023) Characteristics and Effect of Anxiety and Depression Trajectories in Inflammatory Bowel Disease. American Journal of Gastroenterology 118:2, pages 304-316.
Crossref
Crossref
M. Freitas, F. Dias de Castro, V. Macedo Silva, C. Arieira, T. Cúrdia Gonçalves, S. Leite, M. J. Moreira & J. Cotter. (2022) Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast-enhanced ultrasound?. BMC Gastroenterology 22:1.
Crossref
Crossref
Eula Plana Tetangco & Adam C. Stein. (2022) Medical treatment of intestinal Crohn's disease. Seminars in Colon and Rectal Surgery 33:1, pages 100862.
Crossref
Crossref
Manal A. Alfwuaires, Abdulmohsen I. Algefare, Eman Afkar, Sherine Abdel Salam, Heba Ibrahim Abd El-Moaty & Gehan M. Badr. (2021) Immunomodulatory assessment of Portulaca oleracea L. extract in a mouse model of colitis. Biomedicine & Pharmacotherapy 143, pages 112148.
Crossref
Crossref
Sen Yagi, Shinya Furukawa, Kana Shiraishi, Yu Hashimoto, Kazuhiro Tange, Kenichirou Mori, Tomoyuki Ninomiya, Seiyuu Suzuki, Naozumi Shibata, Hidehiro Murakami, Katsuhisa Ohashi, Aki Hasebe, Hideomi Tomida, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda & Yoichi Hiasa. (2021) Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis. BMJ Open Gastroenterology 8:1, pages e000662.
Crossref
Crossref
Emily Wright. (2021) Non‐invasive biomarkers as treatment targets: What do we all need to know?. Journal of Gastroenterology and Hepatology 36:S1, pages 12-13.
Crossref
Crossref
Shimaa El Sharawy, Hemat El-Horany & Ibrahim Amer. (2021) Corrected ESR/Albumin Ratio as a Simple, Practical Marker Predicts the Severity in Egyptian Ulcerative Colitis Patients. The Open Biomarkers Journal 11:1, pages 8-16.
Crossref
Crossref
Fredrik Sævik, Ragnar Eriksen, Geir Egil Eide, Odd Helge Gilja & Kim Nylund. (2021) Development and Validation of a Simple Ultrasound Activity Score for Crohn’s Disease. Journal of Crohn's and Colitis 15:1, pages 115-124.
Crossref
Crossref
Fangwen Zou, Xuemei Wang, Isabella C Glitza Oliva, Jennifer L McQuade, Jennifer Wang, Hao Chi Zhang, John A Thompson, Anusha S Thomas & Yinghong Wang. (2021) Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis. Journal for ImmunoTherapy of Cancer 9:1, pages e002058.
Crossref
Crossref
Walter Reinisch, Krisztina Gecse, Jonas Halfvarson, Peter M Irving, Jørgen Jahnsen, Laurent Peyrin-Biroulet, Gerhard Rogler, Stefan Schreiber & Silvio Danese. (2021) Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease. Inflammatory Bowel Diseases 27:1, pages 106-122.
Crossref
Crossref
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes & Raquel Franco Leal. (2020) Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy 12:12, pages 504-520.
Crossref
Crossref
Tyler McKechnie, Yung Lee, Colin Kruse, Karim Ramji, Jeremy E. Springer, Trevor Wood, Aristithes G. Doumouras, Dennis Hong & Cagla Eskicioglu. (2020) The role of fecal calprotectin in the diagnosis of acute pouchitis following IPAA for ulcerative colitis: a systematic clinical review. International Journal of Colorectal Disease 35:9, pages 1619-1628.
Crossref
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Crossref
Parambir S. Dulai, Vipul Jairath, Reena Khanna, Christopher Ma, Kelly P. McCarrier, Mona L. Martin, Claire E. Parker, Joan Morris, Brian G. Feagan & William J. Sandborn. (2020) Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics 51:11, pages 1047-1066.
Crossref
Crossref
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa & Davide Giuseppe Ribaldone. (2020) Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine 9:5, pages 1323.
Crossref
Crossref
Berna ÖZGÜRSOY URAN, Elif SARITAŞ YÜKSEL, Elif ÜNSAL AVDAL & Burcu ARKAN. (2019) İnflamatuvar barsak hastalıklarında epidemiyolojik özellikler ve hastalık farkındağı; İzmir örneği ile kesitsel bir çalışma. Akademik Gastroenteroloji Dergisi 18:3, pages 112-119.
Crossref
Crossref
Nada Abedin, Teresa Seemann, Sandra Kleinfeld, Jessica Ruehrup, Stefani Röseler, Christian Trautwein, Konrad Streetz & Gernot Sellge. (2019) Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease. Journal of Clinical Medicine 8:12, pages 2025.
Crossref
Crossref
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh & Nassim Fares. (2019) Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Digestive Diseases and Sciences 64:11, pages 3122-3133.
Crossref
Crossref
Sophie Restellini, Che-Yung Chao, Myriam Martel, Alan Barkun, Omar Kherad, Ernest Seidman, Gary Wild, Alain Bitton, Waqqas Afif, Talat Bessissow & Peter L. Lakatos. (2019) Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review. Clinical Gastroenterology and Hepatology 17:7, pages 1265-1275.e8.
Crossref
Crossref
Christopher Ma, Robert Battat, Reena Khanna, Claire E. Parker, Brian G. Feagan & Vipul Jairath. (2019) What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?. Best Practice & Research Clinical Gastroenterology 38-39, pages 101602.
Crossref
Crossref
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung & Chang-Nyol Paik. (2019) The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. The Korean Journal of Internal Medicine 34:1, pages 72-80.
Crossref
Crossref
N A Fadeeva, I A Korneeva, O V Knyazev & A I Parfenov. (2018) Biomarkers of inflammatory bowel disease activity. Terapevticheskii arkhiv 90:12, pages 107-111.
Crossref
Crossref
Saya Tsuda, Reiko Kunisaki, Jun Kato, Mayu Murakami, Masafumi Nishio, Tsuyoshi Ogashiwa, Takeichi Yoshida, Hideaki Kimura & Masayuki Kitano. (2018) Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis. Intestinal Research 16:4, pages 579-587.
Crossref
Crossref
Ashish Kumar Jha, Madhur Chaudhary, Vishwa Mohan Dayal, Amarendra Kumar, Sanjeev Kumar Jha, Praveen Jha, Shubham Purkayastha & Ravish Ranjan. (2018) Optimal cut-off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?. JGH Open 2:5, pages 207-213.
Crossref
Crossref
George Ou, Brian Bressler, Cherry Galorport, Eric Lam, Hin Hin Ko, Robert Enns, Jennifer Telford, Nathan Schaffer, Terry Lee & Greg Rosenfeld. (2018) Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study. Journal of the Canadian Association of Gastroenterology 1:3, pages 99-106.
Crossref
Crossref
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete & Francesco Costa. (2018) From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 24:33, pages 3681-3694.
Crossref
Crossref
Stephan R Vavricka, Henriette Heinrich, Simon Buetikofer, Flavia Breitenmoser, Emanuel Burri, Xiaoye Schneider-Yin, Jasmin Barman-Aksoezen, Luc Biedermann, Michael Scharl, Jonas Zeitz, Gerhard Rogler, Benjamin Misselwitz & Matthias Sauter. (2018) The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterology Journal 6:7, pages 1007-1014.
Crossref
Crossref
Danusia Onişor, Alina Boeriu, Ofelia Pascarenco, Olga Brusnic & Daniela Dobru. (2018) Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study. Revista Romana de Medicina de Laborator 26:3, pages 335-343.
Crossref
Crossref
Romy M. Heilmann, Nora Berghoff, Joanne Mansell, Niels Grützner, Nolie K. Parnell, Corinne Gurtner, Jan S. Suchodolski & Jörg M. Steiner. (2018) Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies. Journal of Veterinary Internal Medicine 32:2, pages 679-692.
Crossref
Crossref
Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang & Byong Duk Ye. (2017) Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. BMC Gastroenterology 17:1.
Crossref
Crossref
Shuhei Fukunaga, Kotaro Kuwaki, Keiichi Mitsuyama, Hidetoshi Takedatsu, Shinichiro Yoshioka, Hiroshi Yamasaki, Ryosuke Yamauchi, Atsushi Mori, Tatsuyuki Kakuma, Osamu Tsuruta & Takuji Torimura. (2017) Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization. International Journal of Molecular Medicine.
Crossref
Crossref
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2017) Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease. Digestive Diseases and Sciences 62:11, pages 3123-3130.
Crossref
Crossref
Dania Alrefai, Jennifer Jones, Wael El-Matary, Susan Whiting, Abdulrahman Aljebreen, Naghmeh Mirhosseini & Hassan Vatanparast. (2017) The Association of Vitamin D Status with Disease Activity in a Cohort of Crohn’s Disease Patients in Canada. Nutrients 9:10, pages 1112.
Crossref
Crossref
Torsten Kucharzik, Bianca M. Wittig, Ulf Helwig, Norbert Börner, Alexander Rössler, Stefan Rath, Christian Maaser, Axel Naumann, Gregor Pelster, Jörg Spengler, Carsten Büning, Enno Gentz, Harald Matthes, Dieter Nürnberg, Adelheid Jung, Jochen Maul, Daniel C. Baumgart, Deike Strobel, Gabriele Manok, Matthias Breidert, Michael Scheurlen, Andreas Stallmach, Uwe Will, Thomas Krause, Rolf-Achim Krüger, Niels Teich, Ingolf Schiefke, Annette Krummenerl, Klaus Fellermann, Rüdiger Kilian, Torsten Kucharzik, Christian Maaser, Ulf Helwig, Volker Meister, Stefan Mielck, Diether Ludwig, Norbert Börner, Stefan Schanz, Robert Kihn, Robert Manfred Hoffmann, Barbara Lanyi, Robert Ehehalt, Burghard Wilborn, Franz Ludwig Dumoulin, Wolfgang Mohl, Andreas Lügering, Thomas Krummenerl, Jan Heidemann, Matthias Pichler, Hans Allescher, Frank Meyer-Hilse, Gerd-Rüdiger Franke, Oliver Bachmann & Martin Fähndrich. (2017) Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity. Clinical Gastroenterology and Hepatology 15:4, pages 535-542.e2.
Crossref
Crossref
Haihao Sun, Richard Vesely, Kerry Jo Lee, Agnes Klein, Mutsuhiro Ikima & Andrew E. Mulberg. (2017) Pediatric Crohn Disease Clinical Outcome Assessments and Biomarkers: Current State and Path Forward for Global Collaboration. Journal of Pediatric Gastroenterology & Nutrition 64:3, pages 368-372.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia & C. Zaltman. (2017) Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México (English Edition) 82:1, pages 46-84.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia & C. Zaltman. (2017) Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México 82:1, pages 46-84.
Crossref
Crossref
Ruth J. Pepper, Juliana B. Draibe, Ben Caplin, Fernando C. Fervenza, Gary S. Hoffman, Cees G. M. Kallenberg, Carol A. Langford, Paul A. Monach, Philip Seo, Robert Spiera, E. William St.Clair, Nadia K. Tchao, John H. Stone, Ulrich Specks, Peter A. Merkel & Alan D. Salama. (2016) Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis & Rheumatology 69:1, pages 185-193.
Crossref
Crossref
Subrata Ghosh, William J. Sandborn, Jean-Frederic Colombel, Brian G. Feagan, Remo Panaccione, Stephen Hanauer, Stefan Schreiber, Laurent Peyrin-Biroulet, Severine Vermeire, Samantha Eichner, Bidan Huang, Anne M. Robinson & Brandee Pappalardo. (2016) Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 22:11, pages 2711-2723.
Crossref
Crossref
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2016) Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease. European Journal of Clinical Investigation 46:10, pages 825-832.
Crossref
Crossref
Sasha Taleban, Kathleen O. Stewart, Darrick K. Li, Prashant Singh, Darrell S. Pardi, Holly C. Sturgeon, Vijay Yajnik, Ramnik J. Xavier, Ashwin N. Ananthakrishnan & Hamed Khalili. (2016) Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes. Digestive Diseases and Sciences 61:9, pages 2627-2635.
Crossref
Crossref
Zhiyan Li, Yan Long, Mingjian Bai, Junxia Li & Zhenru Feng. (2016) Neutrophil and Eosinophil Granule Proteins as Potential Biomarkers of Assessing Disease Activity and Severity in Patients With Ulcerative Colitis. Journal of Clinical Laboratory Analysis 30:5, pages 776-778.
Crossref
Crossref
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch & Waliul Islam Khan. (2016) Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 51:5, pages 434-446.
Crossref
Crossref
Annika Gauss, Peter Sauer, Adolf Stiehl, Christian Rupp, Johannes Krisam, Yvonne Leopold, Petra Kloeters-Plachky, Wolfgang Stremmel & Daniel Gotthardt. (2016) Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis. Medicine 95:17, pages e3510.
Crossref
Crossref
Annika Gauss, Thomas Geiss, Ulf Hinz, Rainer Schaefert, Philipp Zwickel, Anna Zawierucha, Wolfgang Stremmel & Lukas Klute. (2016) Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease. Medicine 95:16, pages e3477.
Crossref
Crossref
Laurent Peyrin-Biroulet, Julián Panés, William J. Sandborn, Séverine Vermeire, Silvio Danese, Brian G. Feagan, Jean-Frédéric Colombel, Stephen B. Hanauer & Beth Rycroft. (2016) Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clinical Gastroenterology and Hepatology 14:3, pages 348-354.e17.
Crossref
Crossref
Jun Lee. (2016) Fecal Calprotectin in Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 67:5, pages 233.
Crossref
Crossref
Maria CappelloGaetano Cristian Morreale. (2016) The Role of Laboratory Tests in Crohn's Disease. Clinical Medicine Insights: Gastroenterology 9, pages CGast.S38203.
Crossref
Crossref
Gaetano C. Morreale, Maria Cappello & Antonio Craxì. 2016. Crohn’s Disease. Crohn’s Disease
15
30
.
Klaus Theede, Susanne Holck, Per Ibsen, Steen Ladelund, Inge Nordgaard-Lassen & Anette Mertz Nielsen. (2015) Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis. Clinical Gastroenterology and Hepatology 13:11, pages 1929-1936.e1.
Crossref
Crossref
Laura E Targownik, Kathryn A Sexton, Matthew T Bernstein, Brooke Beatie, Michael Sargent, John R Walker & Lesley A Graff. (2015) The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. American Journal of Gastroenterology 110:7, pages 1001-1012.
Crossref
Crossref
David L. Suskind. (2015) Author's Response. Journal of Pediatric Gastroenterology & Nutrition 60:4, pages e37.
Crossref
Crossref
Emanuel Burri, Christoph Beglinger, Stefanie von Felten & Frank Serge Lehmann. (2014) Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 60:2, pages 485-491.
Crossref
Crossref
Frank S. Lehmann, Emanuel Burri & Christoph Beglinger. (2014) The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 8:1, pages 23-36.
Crossref
Crossref
Karen A. Chachu & Gary R. Lichtenstein. 2015. Inflammatory Bowel Disease. Inflammatory Bowel Disease
151
160
.
David B. Sachar. (2014) Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2511-2518.
Crossref
Crossref
Irene Muñoz-González, Irene Espinosa-Martos, Juan M. Rodríguez, Ana Jiménez-Girón, Pedro J. Martín-Álvarez, Begoña Bartolomé & M. Victoria Moreno-Arribas. (2014) Moderate Consumption of Red Wine Can Modulate Human Intestinal Inflammatory Response. Journal of Agricultural and Food Chemistry 62:43, pages 10567-10575.
Crossref
Crossref
A. Stallmach, M. Bürger & M. Weber. (2014) Diagnostische OptionenDiagnostic options. Der Internist 55:8, pages 898-905.
Crossref
Crossref
Haihao Sun, Richard Vesely, Jan Taminiau, Peter Szitanyi, Elektra J. Papadopoulos, Maria Isaac, Agnes Klein, Shinobu Uzu, Donna Griebel & Andrew E. Mulberg. (2014) Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 1. Journal of Pediatric Gastroenterology & Nutrition 58:6, pages 679-683.
Crossref
Crossref
Dario Sorrentino, Claudio Avellini, Marco Geraci, Themistocles Dassopoulos, Dimitra Zarifi, Salvatore Francesco Vadalaʼ di Prampero & Gianluca Benevento. (2014) Tissue Studies in Screened First-degree Relatives Reveal a Distinct Crohnʼs Disease Phenotype. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Byong Duk Ye. (2014) How Useful Are Blood and Stool Biomarkers for Detecting Subclinical Mucosal Inflammation in Ulcerative Colitis?. Digestive Diseases and Sciences 59:4, pages 706-707.
Crossref
Crossref
Yi Fengming & Wu Jianbing. (2014) Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014, pages 1-11.
Crossref
Crossref
Floor Bennebroek Evertsz'Pythia T. Nieuwkerk, Pieter C.F. Stokkers, Cyriel Y. Ponsioen, Claudi L.H. Bockting, Robbert Sanderman & Mirjam A.G. Sprangers. (2013) The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers. Journal of Crohn's and Colitis 7:11, pages 890-900.
Crossref
Crossref
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka & Robert Logan. (2013) Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis 7:8, pages 670-677.
Crossref
Crossref
Francisco Rodríguez-Moranta, Triana Lobatón, Lorena Rodríguez-Alonso & Jordi Guardiola. (2013) Calprotectina fecal en el diagnóstico de enfermedades inflamatorias. Gastroenterología y Hepatología 36:6, pages 400-406.
Crossref
Crossref
Stephane Nancey, Gilles Boschetti, Driffa Moussata, Eddy Cotte, Julie Peyras, Charlotte Cuerq, Julie Haybrard, Anne-Laure Charlois, Anne Mialon, Marion Chauvenet, Karine Stroeymeyt, Dominique Kaiserlian, Jocelyne Drai & Bernard Flourié. (2013) Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 19:5, pages 1043-1052.
Crossref
Crossref
Didia Bismara Cury, Sender Jankiel Mizsputen, Clara Versolato, Luciana Odashiro Miiji, Edson Pereira, Maria Aparecida Delboni, Nestor Schor & Alan C. Moss. (2013) Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cellular Immunology 282:1, pages 66-70.
Crossref
Crossref
Alain M. Schoepfer, Christoph Beglinger, Alex Straumann, Ekaterina Safroneeva, Yvonne Romero, David Armstrong, Carsten Schmidt, Michael Trummler, Valérie Pittet & Stephan R. Vavricka. (2013) Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes. Inflammatory Bowel Diseases 19:2, pages 332-341.
Crossref
Crossref
Lill Therese Thorkildsen, Felix Chinweije Nwosu, Ekaterina Avershina, Petr Ricanek, Gøri Perminow, Stephan Brackmann, Morten H. Vatn & Knut Rudi. (2013) Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients. Gastroenterology Research and Practice 2013, pages 1-13.
Crossref
Crossref
Yoon Suk Jung, Jae Jun Park, Seung Won Kim, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2012) Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Digestive and Liver Disease 44:11, pages 897-903.
Crossref
Crossref
Laura E. Targownik, William D. Leslie, Rachel Carr, Ian Clara, Norine Miller, Linda Rogala, Lesley A. Graff, John R. Walker & Charles N. Bernstein. (2012) Longitudinal Change in Bone Mineral Density in a Population-Based Cohort of Patients with Inflammatory Bowel Disease. Calcified Tissue International 91:5, pages 356-363.
Crossref
Crossref
John R. Cangemi. (2012) Fecal Calprotectin. Journal of Clinical Gastroenterology 46:6, pages 440-441.
Crossref
Crossref